varicose vein treatment market overview:
The global varicose vein treatment market was valued at $ 376.64 million in 2017, and is projected to reach $ 589.06 million by 2025, growing at a CAGR of 5.7% from 2018 to 2025.
Varicose veins are abnormal, dilated blood vessels caused by weakening of the vessels walls. These veins appeared to be swollen, twisted, cluster of blue or purple veins under the skin. Varicose vein disorder affects millions of people all around the world Symptoms usually appear at age of 40 and generally appeared in the legs. Varicose vein is harmful to health if they lead to venous stasis ulcers, phlebitis, thrombosis, venous hemorrhage, or fungal and bacterial infections. According to the American Society of Vascular surgery, at least 20 to 25 million Americans are suffering from varicose vein, among them 17% are men and 33% are women. The varicose vein treatment analysis is done on the basis of the exhaustive primary and secondary regional wise to understand the factors responsible for growth and factors hampering the growth of the market.
Factors such as increase in incidence of varicose vein problem, rise in geriatric population, advanced varicose vein treatment devices, engagement in occupation that increases the prevalence of varicose vein treatment and technological advancements globally, drive the growth of the market. Moreover, increase in level of awareness, and development in the emerging markets create numerous opportunities in the varicose vein treatment market.
Varicose Vein Treatment Market Segmentation
The global varicose vein treatment market is segmented based on procedure, product and services, end user, and region. Based on product, the market is segmented into endovenous ablation, injection sclerotherapy, surgical ligation/stripping. Based on product, the market is divided into ablation devices, sclerotherapy injection and other. Ablation devices is further bifurcated into radiofrequency ablation devices, laser ablation devices and others. Based on the end user the market is segmented into hospitals, clinics, and ambulatory centers. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Segment review
Based on procedure, the global varicose vein treatment market is categorized into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. At present, the sclerotherapy segment is the major revenue generating segment as the sclerotherapy procedure is a painless procedure and on the same day of surgery the patient can go to home.
Based on product, the global varicose vein treatment market is categorized into sclerotherapy injection, ablation devices and others. At present, the sclerotherapy injection is the major revenue generating segment as surgery with ablation devices is less painful and leaves no stretch marks. Patients can go home on the same day of the surgery.
Based on end user, the global varicose vein treatment market is categorized into hospitals, clinics, and home use. At present, the hospital segment is the major revenue generating segment due to availability of nurse and healthcare professionals who offer proper guidance about handling the device.
Snapshot of Asia-Pacific varicose vein treatment market
Asia-Pacific provides lucrative growth opportunities for the key players operating in the varicose vein treatment market due to high population base, development in healthcare infrastructure, and increase in geriatric population. However, as insurance companies do not cover the entire material expenses of a surgery, it is estimated to hamper the market growth in Asia-Pacific.
The key players profiled in this report include Medtronic, Lumenis, Alma Lasers Ltd., Angiodynamics, Inc., Biolitec AG, BTG PLC, Energist Ltd., Sciton Inc., WONTECH Co., Ltd., and Syneron.
Key Benefits for varicose vein treatment market:
The study provides an in-depth analysis of the varicose vein treatment market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis varicose vein treatment market trends from 2018 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities in the varicose vein treatment market share.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global varicose vein treatment market growth.
Varicose Vein Treatment Market, by Procedure Report Highlights
| Aspects | Details |
 By Procedure |
|
 By Product |
|
 By End User |
|
 By Region |
|
 Key Market Players | BTG International Ltd, Syneron Medical Ltd, Sciton Inc, Alma Lasers, WON TECH Co., Ltd, Angiodynamics Inc, Medtronic, Energist Ltd, Lumenis, biolitec AG Untere Viaduktgasse |
Analyst Review
Varicose veins are abnormal, dilated blood vessels caused by weakening in the vessel’s walls. These veins appear to be swollen, twisted, cluster of blue or purple veins under the skin. The use of devices including endovenous ablation devices and sclerotherapy procedure is expected to increase due to growth in geriatric population and rise in prevalence of varicose vein problem due to engagement in professions which require prolong standing.
Increase in geriatric population and technological advancements and advanced varicose vein treatment devices are expected to fuel the market growth during the forecast period. However, risk factors associated with the treatment devices and healthcare professionals who have less expertise in handling the lasers devices are expected to hinder the growth of the global market.
North America is expected to remain dominant during the forecast period due to supportive reimbursement policies in healthcare system, higher number of varicose vein cases. In addition, Asia-Pacific and LAMEA are expected to provide lucrative opportunities for the growth of the global market during the forecast period due to developments in healthcare infrastructure with a rise in demand for advanced medical facilities and increase in geriatric population.
Loading Table Of Content...
